Colonics
 
About Me

Colonics resources

Recent Posts
Menu
Calendar
«  March 2015  »
MonTueWedThuFriSatSun
 1
2345678
9101112131415
16171819202122
23242526272829
3031 

Friends
    Links


    Entry 1 of 3278
    Last Page | Next Page
    3/4/2010 - FDA approves CSL Behring's Hizentra for PI
    Posted in Medical News

    CSL Behring announced today that the U.S. Food and Drug supervision (FDA) has granted buying allow for HizentraTM, Immune Globulin Subcutaneous (Human), 20% Liquid, for treating clients diagnosed with primary immunodeficiency (PI). A once weekly immunoglobulin (Ig) or try your search for "replacement" at:

    amazon.com - shop for books therapy, Hizentra provides productive shelter against bug* by surroundings a steady and normal level of immunoglobulin in the body.

    More: - Continued here

    Share |

    :: Send to a Friend!

    Share and enjoy
    • Digg
    • del.icio.us
    • DZone
    • Netvouz
    • NewsVine
    • Reddit
    • Slashdot
    • StumbleUpon
    • Technorati
    • YahooMyWeb
     
    portfolio